Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

“April 1, 2002 Intelligence: Late Breaking Lab News”

Genaissance Pharmaceuticals Inc. announced it has identified genetic markers useful in identifying which people will respond best to cholesterol-lowering drugs. A study of 500 patients taking Lipitor, Pravachol, and Zochor compared their response to drugs over 16 weeks with a genetic profile that analyzed 100 genes. Among other things, the company says it may use …

“April 1, 2002 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

Comments

;

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.